MedTrace Logo

Real-life Use of Niraparib in a Patient Access Program in Norway

NCT04785716 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2021-03-08

No results posted yet for this study

Summary

Retrospective observational study of patients treated with niraparib in an individual patient access program in Norway.

Conditions

Interventions

DRUG

Niraparib

Niraparib provided through the patient access program

Sponsors & Collaborators

  • University Hospital of North Norway

    collaborator OTHER

  • St. Olavs Hospital

    collaborator OTHER

  • Haukeland University Hospital

    collaborator OTHER

  • Sorlandet Hospital HF

    collaborator OTHER_GOV

  • Kristina Lindemann

    lead OTHER

Principal Investigators

  • Kristina Lindemann, MD · Oslo University Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-31
Primary Completion
2020-08-03
Completion
2020-08-03

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04785716 on ClinicalTrials.gov